Ossur Hf : Interim Report Q4 2017 and Annual Report 2017
Announcement no. 8/20185 February 2018 Highlights · Sales in Q4 2017 amounted to USD 154 million, corresponding to 7% organic growth. Sales for FY 2017 amounted to USD 569 million, corresponding to 8% growth and 5% organic growth, both measured in local currency. · Prosthetics segment grew 11% organically in Q4 2017 with an excellent contribution from the recently launched upgrades of the RHEO KNEE®. Growth in the B&S segment was 3% organic in the quarter. · Gross profit in Q4 2017 amounted to USD 97 million or 63% of sales. Gross profit for FY 2017 amounted to USD 355